Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
On Tuesday, November 26, 2024, HBHL hosted a Mentorship Lunch that brought together experienced industry professionals and over 40 McGill graduate students, postdocs and postgrads over coffee and...
RSS